Avita Medical Inc (RCEL) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Avita Medical Inc   (NASDAQ: RCEL)
 

Avita Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Avita Medical Inc inventory turnover ratio, the Avita Medical Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.58 in the third quarter 2026, yet the ratio remained below the average, as RCEL's market remain challenging.Average inventory processing period, for the Avita Medical Inc in Sep 30 2026 quarter, has decreased to 141 days, compare to 167 days, in the Jun 30 2026 quarter.

Within Healthcare sector 153 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1468 in the second quarter 2026, to 1588.

RCEL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Avita Medical Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RCEL Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -33.66 % -29.84 % -27.14 % -4.72 % 16.23 %
Y / Y Cost of Sales Growth 30.94 % 13.43 % 24.36 % 44.96 % -0.09 %
Inventory Turnover Ratio (TTM) 2.58 2.18 1.94 1.7 1.55
RCEL's Total Ranking # 1588 # 1468 # 1034 # 1067 #
Average inventory processing period 141 167 188 215 236
Seq. Inventory Growth -9.15 % -13.57 % -11.68 % -4.34 % -3.93 %
Seq. Cost of Sales Growth 6.05 % 11.69 % 6.6 % 3.7 % -8.13 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 62
Healthcare Sector # 154
Overall Market # 1588

Inventory Turnover Ratio Statistics
High Average Low
6.64 2.74 1.28
(Jun 30 2021)   (Jun 30 2024)



RCEL Company Profile >> Back to RCEL Efficiency Comparisons >> Compare RCEL Inventory Turnover Ratio to its Competitors

Financial Statements
Avita Medical Inc 's Inventories $ 5 Millions Visit RCEL's Balance sheet
Avita Medical Inc 's Cost of Revenues TTM $ 15 Millions Visit RCEL's Income Statement
What are RCEL's Sales? Visit RCEL's Sales by Segment

Other Inventory Turnover Ratios
Avita Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RCEL's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RCEL's Competitors
Inventory Turnover Ratio for RCEL's Suppliers
Inventory Turnover Ratio for RCEL's Customers

You may also want to know
RCEL's Sales Growth Rates RCEL's Pe Price to earnings ratio RCEL's Receivables Turnover Ratio RCEL's Stock Quote
RCEL's Net Income Growth Rates RCEL's Ps Price to Sales ratio RCEL's Sales per Employee RCEL's Asset Turnover Ratio
RCEL's Net Margin RCEL's Pb Price to Book ratio RCEL's Financial Strength Ratios RCEL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions

Date modified: 2026-11-08T19:41:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.